Abstracts


Keyword Index
 

A B C D E F G H I J K L M N O P Q R S T U V W Y X Z



"top

"L. GONGYLOPHORUS"'     [L-012]


&top

α-AMYLASE     [J-002]

β-CATENIN     [O-011]

β-CYCLODEXTRIN     [L-015]

β-D-FRUCTOFURANOSIDASE     [L-001]

β-SELENOAMINES     [T-018]

β-TRYPSIN     [L-015]

β-XYLOSIDASE     [L-002]

γCDCPLI.     [B-015]


(top

(NA+, K+)-ATPASE     [L-025], [L-011]

(NA+,K+)-ATPASE     [L-024]

(P-BTHTX-I)2     [R-026]


1top

1,25-DIHYDROXYVITAMIN D3     [T-026]


2top

2'-HYDROXYFLAVANONE     [SP-24 - 2]

2,4-D.     [A-037]

24-C-STEROL-METHYLTRANSFERASE     [C-002]

2A-LIKE MOTIFS     [G-016]

2D ELECTROPHORESIS     [S-002]


3top

3D BIOMOLECULES     [K-012]

3D CELL CULTURES     [P-010]


Atop

AβOS-TOXICITY     [SP-09 - 4]

A. FUMIGATUS     [A-029]

AAG2 CELLS     [E-039]

AAK1     [B-010]

ABTS     [F-041]

ACANTHOSCURRIA GOMESIANA     [E-047]

ACANTHOSCURRIA JURUENICOLA     [SP-22 - 4]

ACCELERATED MOLECULAR DYNAMICS     [C-004]

ACETYLCHOLINESTERASE     [Q-012]

ACRIDINE ORANGE     [B-027]

ACTIN CYTOSKELETON     [B-028]

ACTINOBACTERIA     [L-008]

ACTION MECHANISM     [J-006]

ACTIVITY     [L-029], [L-015]

ACUTE LYMPHOBLASTIC LEUKEMIA     [I-013], [P-014]

ACUTE MYELOID LEUKEMIA     [B-036]

ACUTE PROMYELOCYTIC LEUKEMIA     [B-023]

ADENANTHERA PAVONINA L.     [J-014]

ADENOSINE DEAMINASE (ADA)     [L-021]

ADHESION     [B-032]

ADIPOCYTE     [I-028]

ADIPOCYTES     [B-005]

ADIPOKINE     [BM-04]

ADIPOKINES     [BM-05]

ADIPONECTIN     [N-012], [D-005]

ADIPOSE TISSUE     [SP-15 - 3]

ADMIXED POPULATION     [I-034], [I-023]

ADRENOCORTICAL TUMOR     [B-024]

AEDES AEGYPTI     [L-003], [J-012], [N-009], [E-021], [E-029], [E-013], [E-014], [E-039], [A-015]

AEDES FLUVIATILIS     [E-034]

AEROMONAS     [G-017], [G-007]

AFFINITY     [J-019]

AFM     [L-009]

AGAR SUBSTITUTION     [J-014]

AGARICUS BISPORUS     [SP-13 - 1]

AGES     [J-067], [A-025]

AGGLUTININS     [R-019]

AGGREGATION     [M-019], [C-009]

AGING     [H-020], [I-009]

AKT/MTOR     [I-018]

ALKALINE PHOSPHATASE     [V-008], [BM-02], [BM-03], [BM-02], [V-006], [BM-02]

ALKYL GALLATES     [T-001]

ALKYLATION BASE DAMAGE     [I-029]

ALLIUM CEPA     [T-027]

ALP ACTIVITY     [V-003]

ALPHA SYNUCLEIN     [Q-010]

ALPHA TRYPSIN     [L-029]

ALPHA-LIPOIC ACID     [Q-011]

ALPHA-SYNUCLEIN     [M-036]

ALPHA-TOCOPHEROL     [D-008]

ALPHA-TRYPSIN     [L-030]

ALZHEIMER DISEASE     [C-015]

ALZHEIMER'S     [SP-01 - 3]

ALZHEIMER'S DISEASE     [SP-09 - 4], [SP-09 - 5]

ALZHEIMER’S DISEASE     [J-048], [J-026]

AMAZON     [S-005], [J-049]

AMAZON SOILS     [S-004]

AMBURANA CEARENSIS     [J-057]

AMINOCHROME     [Q-002]

AMINOTHIAZOLES DERIVATIVE     [C-015]

AMPHIBIAN     [R-025]

AMYLASES     [J-016], [SP-16 - 3]

AMYLOID     [P-023]

AMYLOID AGGREGATES     [M-015]

AMYLOID FIBRILS     [M-036]

AMYLOID-LIKE AGGREGATES     [D-025]

AMYOTROPHIC LATERAL SCLEROSIS     [C-019], [C-028]

ANACARDIACEAE     [T-012]

ANACARDIUM HUMILE     [F-023]

ANACARDIUM OCCIDENTALE     [T-003], [B-001], [S-012]

ANAPLEROTIC ACTIVITY     [SP-15 - 2]

ANGIOGENESIS     [B-028], [SP-21 - 1], [I-005], [I-006], [I-016]

ANGIOTENSIN II     [R-014]

ANGIOTENSINS     [M-032]

ANNEXIN V     [BM-02], [V-004]

ANT VENOM     [J-046]

ANTENNAE     [E-044]

ANTI-ANGIOGENIC     [B-003]

ANTI-DERMATOPHYTIC POTENTIAL     [F-012]

ANTI-INFLAMMATORY     [M-014], [J-015]

ANTI-INFLAMMATORY ACTIVITY     [F-035]

ANTI-NUTRITIONAL FACTORS     [R-019]

ANTI-ULCER     [F-016]

ANTIBACTERIAL ACTION     [R-011]

ANTIBACTERIAL ACTIVITY     [R-012], [R-034], [F-038], [M-008], [H-005]

ANTIBIOTIC DISCOVERY     [SP-25 - 1]

ANTIBIOTICS     [B-001]

ANTICANCER     [M-001]

ANTICANCER ACTIVITY     [P-025]

ANTICARSIA GEMMATALIS     [E-010]

ANTICHIMOTRYPSIN     [R-020]

ANTICOAGULANT     [SP-05 - 4], [SP-05 - 1], [O-018], [O-001]

ANTICOAGULANT ACTIVITY     [O-017], [O-008]

ANTICOAGULANTE     [SP-13 - 2]

ANTIFUNGAL PROTEIN     [F-034]

ANTIHYPERNOCICEPTIVE     [J-015]

ANTILEISHMANIAL ACTIVITY     [B-030]

ANTIMETASTATIC EFFECT     [O-039]

ANTIMICROBIAL     [M-001], [F-026], [F-028]

ANTIMICROBIAL ACTIVITY     [E-047], [G-013], [J-072], [J-037], [J-053], [R-024], [R-023], [J-032]

ANTIMICROBIAL AGENTS     [R-028]

ANTIMICROBIAL PEPTIDE     [C-010], [R-005]

ANTIMICROBIAL PEPTIDES     [R-013], [R-006], [E-031], [SP-22 - 3], [R-010], [R-017], [R-027], [J-052], [E-010], [J-024]

ANTIMICROBIAL PROTEIN     [J-011]

ANTIOBESITY     [B-016]

ANTIOXIDANT     [T-002], [T-014], [T-012], [O-018], [E-026], [N-015], [O-006], [T-024]

ANTIOXIDANT ACTIVITY     [P-012], [H-011], [T-029]

ANTIOXIDANT DEFENSES     [T-022]

ANTIOXIDANT EFFECT     [F-020]

ANTIOXIDANT ENZYMES     [F-027], [F-007]

ANTIOXIDANTS     [Q-013], [T-009], [B-016], [T-020], [M-041], [J-005], [K-013]

ANTIOXIDATIVE ENZYMES     [F-032]

ANTIPLATELET THERAPY     [N-014]

ANTIPROLIFERATIVE ACTIVITY     [O-034], [O-017]

ANTIPROLIFERATIVE POTENCIAL     [J-064]

ANTITHROMBOTIC ACTIVITY     [O-016]

ANTITRYPSIN     [R-020]

ANTITUMOR DRUG     [B-037]

ANTITUMOR PEPTIDES     [R-016]

ANXIOLYTIC     [P-007]

APICOMPLEXA     [H-017]

APIGENIN     [Q-002]

APOE KNOCK-OUT MICE     [J-048], [J-026]

APOEKO     [J-068]

APOPTOSIS     [B-038], [E-004], [J-068], [G-010]

APPROACHES     [SP-02 - 4], [SP-08 - 3]

AQUEOUS EXTRACT     [F-040]

ARABIDOPSIS     [SP-11 - 4], [SP-11 - 1]

ARABINOGALACTAN     [O-028]

ARACHNIDS     [SP-22 - 3]

ARCTIUM LAPPA     [F-016]

ARHGAP21     [B-022]

ARTERIAL STIFFNESS     [I-012]

ARTHROPOD DUOX     [N-010]

ARTIFICIAL INTELLIGENCE     [C-022]

ARTOCARPUS INCISA     [F-037], [M-031]

ASCIDIAN     [M-004]

ASPERGILLUS NIDULANS     [L-002]

ASPERGILLUS NIVEUS     [L-001]

ASPERGILLUS SPP.     [S-004]

ASSEMBLY     [G-019]

ASSESSMENT     [K-008]

ASTROCYTES     [Q-018]

ATAC-SEQ     [SP-18 - 1]

ATBZIP63     [SP-11 - 4]

ATG6     [E-027]

ATHEROSCLEROSIS     [D-008], [D-007]

ATLANTIC FOREST     [P-025]

ATOMIC FORCE MICROSCOPY     [BM-02]

ATP BINDING SITE     [M-026]

ATPASES     [SP-21 - 1]

ATRIAL FIBRILLATION     [I-024]

ATROSLYSIN III     [P-018]

ATTA SEXDENS RUBROPILOSA     [J-021]

ATTAINMENT OF THE EXPECTATIONS     [K-006]

AURORA KINASE     [E-007], [B-024]

AUTO-OXIDATION     [M-022]

AUTOPHAGY     [B-026], [I-018], [A-025], [E-043], [E-028]

AUXIN     [F-042]

AZASTEROL     [C-002]


Btop

BABESIA     [H-017]

BABESIA BOVIS     [SP-24 - 3]

BACILLUS SP.     [J-001]

BACILLUS SUBTILIS     [G-021]

BACTERIA     [S-011], [J-045], [N-001]

BACTERIA, BIOPHYSICS     [R-005]

BACTERIAL RESISTANCE     [S-021]

BAHIA     [G-003]

BAMBA     [SP-07 - 4]

BARK     [S-003]

BARRIER PROPERTIES     [O-029]

BASE EXCISION REPAIR     [I-029]

BASIC EDUCATION     [K-005]

BCR-ABL1     [P-022]

BEHAVIOR     [Q-016]

BERARDINELLI SYNDROME     [SP-23 - 2]

BERARDINELLI-SEIP     [BM-06]

BERGAMOT ESSENTIAL OIL     [P-004]

BETA-CATENIN     [B-024]

BETA-FRUCTOSIDASES     [E-032]

BETA-GLUCOSIDASE     [M-024], [L-028]

BEZAFIBRATE     [SP-24 - 4]

BIACTIVE MOLECULES     [J-024]

BIDIRECTIONAL COMMUNICATION     [SP-04 - 1]

BIFIDOBACTERIUM SP     [D-015]

BIG DATA     [CF-7]

BINDING AFFINITY PREDICTION     [C-024], [C-005]

BINDING SITE     [C-027]

BIOACTIVE     [SP-25 - 2]

BIOACTIVE COMPOUNDS     [O-009], [R-025]

BIOACTIVE FLAVONOIDS     [J-067]

BIOACTIVE MOLECULES     [E-046]

BIOACTIVE PEPTIDE     [R-033]

BIOACTIVE PEPTIDES     [R-004]

BIOACTIVE PRODUCTS     [F-009]

BIOACTIVE PROTEIN     [R-009], [R-008]

BIOASSAY     [J-017]

BIOCHEMICAL PARAMETERS     [SP-12 - 4]

BIOCHEMICALLY     [B-006]

BIOCHEMISTRY     [K-003], [K-014]

BIOCHEMISTRY EDUCATION     [K-008]

BIOCHEMISTRY LABORATORY     [K-011]

BIOCOMPATIBILITY     [BM-05]

BIOCONJUGATE     [J-006]

BIODIESEL     [J-028]

BIODIESEL QUALITY PARAMETERS     [J-028]

BIOENERGETICS     [SP-21 - 2]

BIOENERGETICS RESPONSE     [A-035]

BIOENGINEERING     [B-021]

BIOEXTRACTS     [J-017]

BIOFILM     [N-005], [R-026], [J-010]

BIOFUEL     [C-011]

BIOFUELS     [J-047], [C-021], [C-012]

BIOGENIC AMINES     [L-010], [L-026]

BIOINDICATORS     [I-011], [L-017]

BIOINFORMATICS     [R-005], [M-017], [N-002], [R-010], [N-014], [M-003], [N-006]

BIOINSECTICIDAL     [M-001]

BIOINSECTICIDE     [SP-22 - 1], [E-029]

BIOLOGICAL ACTIVITIES     [O-022], [O-031]

BIOLOGICAL CHARACTERIZATION     [J-046]

BIOLOGICAL CONTROL     [F-043]

BIOLOGICAL EFFECTS     [I-031], [I-020], [I-010]

BIOLOGICAL INDICATORS     [L-019]

BIOMARKER     [D-002], [I-023]

BIOMARKERS     [D-019], [SP-02 - 1], [N-007], [SP-17 - 2], [D-028]

BIOMATERIALS     [BM-05]

BIOMECHANICAL ANALYSES AND ALP ACTIVITY     [V-001]

BIOMINERALIZATION     [BM-02]

BIOPHYSICS     [C-010]

BIOPOLYMER     [V-005]

BIOPROSPECTING     [O-018]

BIOPROSPECTION     [O-036]

BIOREMEDIATION     [S-013], [J-045], [J-039]

BIOSENPS     [J-008]

BIOSENSORS     [SP-02 - 5]

BIOSURFACTANT     [J-039]

BIOSYNTHETIC     [SP-07 - 2]

BIOTECHNOLOGICAL     [SP-25 - 2]

BIOTECHNOLOGICAL TOOLS     [SP-25 - 04]

BIOTECHNOLOGY     [J-033], [K-001], [O-020]

BIP     [S-020]

BIPOLAR DISORDER     [B-019], [C-001], [D-006]

BLACK PEPPER     [J-030]

BLACKBERRY     [R-030]

BLASTOCLADIELLA EMERSONII     [H-010]

BLOOD CLOTTING     [O-007]

BLOOD COAGULATION     [M-027], [D-013]

BLOOD-BRAIN BARRIER     [Q-018]

BME26     [E-019]

BME26 EMBRYO TICK CELL LINE     [E-005]

BNIP3L     [B-036]

BONE     [BM-06], [B-009], [BM-03], [BM-05], [BM-04]

BONE BIOLOGY     [BM-01]

BONE DISEASE     [BM-06]

BONE LOSS     [BM-04]

BONE METABOLISM     [BM-06]

BONE METHABOLISM     [BM-06]

BONE MINERAL DENSITY     [BM-04]

BONE MINERAL DISORDERS     [BM-03]

BONE MORPHOGENETIC PROTEIN     [BM-01]

BONE REGENERATION     [O-033], [V-003]

BONES     [BM-04]

BOOPHILUS MICROPLUS     [E-035]

BOTHROPS ALTERNATUS     [I-020], [M-027], [G-013]

BOTHROPS JARARACUSSU     [I-010]

BOTHROPS MOOJENI     [I-021], [M-043], [M-028], [I-031]

BOTHROPS PAULOENSIS     [B-029]

BOVINE HEPARIN     [O-039]

BOVINE LACTOFERRIN     [M-010]

BOWMAN-BIRK INHIBITOR     [F-033]

BRAIN     [A-036], [Q-011], [I-027], [Q-004], [D-018]

BRAIN CANCER     [J-041]

BRAIN ENERGY METABOLISM     [A-024], [A-005]

BRAIN-DERIVED NEUROTROPHIC FATOR     [Q-005]

BRAZILIAN CERRADO     [L-005]

BRCA1     [I-026]

BRCT     [N-018]

BREADFRUIT     [F-037]

BREAST CANCER     [I-004], [B-012], [B-035], [O-010], [B-004], [I-015]

BREAST CANCER CELLS     [B-017]

BROMELAIN     [J-061]

BROTHEAS AMAZONICUS     [E-003]

BROWN SEAWEED     [O-035], [O-022], [O-031], [O-037], [SP-13 - 3]

BROWNING     [I-028]

BTEX     [J-045]

BULLFROG     [L-006]


Ctop

C-MYC     [SP-15 - 1]

C. ALBICANS     [O-038]

C. AMBROSIOIDES     [F-002]

C.SILIQUA     [T-021]

C57BL/6J     [A-012]

CACHEXIA     [J-070]

CADMIUM     [A-004], [J-042]

CAENORHABDITIS ELEGANS     [T-029], [T-004], [F-014]

CALCIUM     [A-043], [B-039], [A-034]

CALCIUM OXALATE CRYSTALS MORPHOLOGY     [O-021]

CALCIUM SENSITIVITY     [H-013]

CALLINECTES DANAE     [L-020]

CALORIC RESTRICTION     [SP-20 - 5]

CALORIE RESTRICTION     [A-010]

CAMPATH-1H     [C-003]

CANAVALIA ENSIFORMIS     [F-018]

CANCER     [F-031], [M-020], [SP-17 - 3], [R-035], [D-028], [P-002], [O-025], [S-016], [A-032], [P-008], [P-004], [U-001], [T-011]

CANCER AND GLUCOSE     [SP-17 - 4]

CANCER AND PLANT CELLS     [SP-21 - 2]

CANCER CELLS     [SP-17 - 1]

CANCER PROTEOMICS     [S-007]

CANCER STEM CELL     [P-010]

CANDIDA ANTARCTICA     [L-004]

CANDIDA SP     [J-034]

CANDIDA SPP     [F-034]

CANINE VISCERAL LEISHMANIASIS     [J-056]

CAPABILITIES     [SP-02 - 2]

CAPACITANCE     [J-027]

CAPACITY BUILDING     [SP-19 - 4]

CARBAPENEMASE-PRODUCING K. PNEUMONIAE     [J-031]

CARBOHYDRATE     [I-033], [C-006]

CARBOHYDRATE-BINDING MODULE     [M-006]

CARBOHYDRATES     [K-009]

CARBOXYLESTERASE STRUCTURE     [N-009]

CARDIAC HYPERTROPHY     [D-017]

CARDIOLIPIN     [A-010]

CARDIOMYOPATHIES     [M-037]

CARDIOPROTECTION     [S-009]

CARDIOVASCULAR DISEASES     [D-019]

CARDISOMA GUANHUMI     [L-026]

CAROTENOIDS     [J-005]

CARS MICROSCOPY     [O-041]

CAS9     [I-017]

CASEIN     [M-008]

CASPASE-3     [C-015]

CASPASE-3 INHIBITORS     [P-020]

CASPASES     [E-004]

CASTOR BEAN     [F-008], [F-006]

CATHEPSIN     [E-009]

CATHEPSIN L-LIKE     [E-041]

CATIONIC PEPTIDES     [J-031]

CAVEOLIN-1     [SP-09 - ], [B-007], [B-025], [B-032]

CANCER DE PROSTATA;     [I-037]

CCK     [R-018]

CD20     [C-013]

CD38     [A-005]

CDK11     [M-021]

CDNA LIBRAY     [J-029]

CEIBA SPECIOSA     [T-029]

CELEGANS     [T-021]

CELL ADHESION     [B-020], [J-020]

CELL ADHESION MOLECULES     [SP-04 - 1]

CELL CHEMICAL COMPOSITION     [K-002]

CELL CYCLE     [E-007], [B-014]

CELL DEATH     [B-012], [D-016], [B-027]

CELL DIFFERENTIATION     [B-023]

CELL MEMBRANE     [P-003]

CELL MEMBRANE MODELS     [V-006]

CELL SENESCENCE     [SP-08 - 1]

CELL THERAPY     [I-006], [I-005]

CELL TOXICITY     [SP-12 - 1]

CELL TRAFFICKING     [SP-10 - 1]

CELLS BME-26     [E-035]

CELLULAR DIFFERENTIATION     [H-010]

CELLULASE     [C-021], [M-006]

CELLULOLYTIC ENZYME     [J-051]

CELLULOSE     [C-012]

CENTRAL NERVOUS SYSTEM     [Q-015]

CEREBRAL CORTEX     [T-026]

CEREBRAL ENDOTHELIAL CELLS     [Q-018]

CGMP     [CF-4]

CHAGAS CARDIOMYOPATHY     [D-001]

CHAGAS DISEASE     [I-036], [D-004], [H-007], [SP-23 - 1], [D-003], [H-019], [D-002], [SP-14 - 2]

CHAGAS DISEASE, RHODNIUS PROLIXUS     [E-037]

CHAGAS DISEASE.     [D-024]

CHAGAS' DISEASE     [H-002]

CHAGAS'S DISEASE     [P-015]

CHALCOGENURANES     [C-020]

CHALCONES     [C-016]

CHAPERONES     [D-012]

CHARACTERIZATION     [L-007], [M-002]

CHEMICAL CHARACTERIZATION     [H-015]

CHEMICAL MODIFICATION     [O-007]

CHEMICAL PRESERVATIVES     [F-028]

CHEMICAL SULFATION     [O-001]

CHEMILUMINESCENCE     [D-028]

CHEMORESISTANCE     [A-018]

CHEMOTHERAPY     [I-015], [SP-24 - 2]

CHENOPODIUM QUINOA     [Q-001]

CHIMERIC ANTIGEN     [H-002]

CHITIN-BINDING PROTEIN     [J-015]

CHITINASE     [F-019]

CHITINASES     [F-036]

CHO CELLS     [O-026]

CHOLECYSTOKININ     [R-009]

CHOLESTEROL     [SP-23 - 3], [V-008], [V-009]

CHOLESTEROL HYDROPEROXIDE     [T-008]

CHOLINE ACETYLTRANSFERASE     [Q-012]

CHONDROCYTE     [BML-01]

CHROMATIN     [SP-18 - 1], [SP-24 - 4]

CHROMATIN STRUCTURE     [CF-5]

CHROMOSOMAL REARRANGEMENT     [N-008]

CHRONIC KIDNEY DISEASE     [BM-03]

CHRONIC KIDNEY DISEASE (CKD)     [BM-03]

CHRONIC MYELOID LEUKEMIA     [P-022]

CIGB-300     [P-019]

CIRCADIAN CLOCK     [SP-11 - 1], [F-042]

CIRCULAR DICHROISM     [J-018], [R-003]

CITOCINAS     [I-037]

CITOTOXICITY     [F-038]

CITOTOXITY     [B-030]

CITRUS SINENSIS     [J-009]

CK2     [P-019]

CLATHRIN     [E-017]

CLEFT LIP AND PALATE     [I-001]

CLIBANARIUS SYMMETRICUS     [L-011]

CLONING     [G-015]

CLOPIDOGREL TOXICITY     [P-021]

CLOTTING CASCADE     [E-031]

CNPQ     [G-020]

CO-EVOLUTIONARY BIOENERGETICS     [SP-21 - 3]

COAGULATION     [SP-14 - 1]

COAGULATION FACTORS     [D-026]

COCKROACH     [E-030]

COGULANT PROTEIN     [J-040]

COINFECTION     [I-003]

COLLAGEN I     [V-010]

COLLAGENASE     [V-010]

COLORECTAL CANCER     [J-020], [S-005], [O-012], [N-008], [SP-17 - 2]

COLOSSOMA MACROPOMUM     [G-007]

COMBINED STRESSES     [F-006]

COMPARATIVE MODELING     [C-026]

COMPARING     [CF-6]

COMPLEX FRUTALIN-D-MANNOSE     [M-031]

COMPUTATIONAL BIOCHEMISTRY     [C-029]

COMPUTATIONAL BIOLOGY     [M-003]

COMPUTATIONAL PREDICTIONS     [C-008], [C-018]

CONDITIONED MEDIUM     [U-003]

CONGENITAL GENERALIZED LIPODYSTROPHIES     [SP-23 - 2]

CONGO RED     [M-015]

COPD     [SP-14 - 3]

COPPER     [SP-12 - 3]

CORE PROTEIN     [M-009], [G-019]

COUMARINS     [Q-008]

CPSMV     [F-011]

CRATABL     [M-023]

CRATAEVA TAPIA     [M-023]

CREATINE KINASE     [A-009]

CRISPR     [I-017]

CRISPR/CAS9     [H-004]

CROPS     [L-005]

CRYPTOCOCCUS FLAVUS     [J-002]

CRYSTALLOGRAPHY     [M-038], [SP-14 - 1], [M-016]

CUCURBITACEAE     [F-026]

CUPIENNIUS SALEI     [SP-22 - 2]

CUTICLE HYDROCARBONS     [E-037]

CYANOBACTERIA     [J-028], [J-049]

CYSTATIN     [E-009], [E-040]

CYSTEINE PROTEASE INHIBITORS     [C-020]

CYSTEINE PROTEINASE     [B-031]

CYTOCHROME     [SP-01 - 2]

CYTOCHROME C DIMER     [T-008]

CYTOKINES     [M-040], [Q-009]

CYTOSKELETON     [B-022]

CYTOTOXIC ACTIVITY     [P-002]

CYTOTOXICITY     [P-004], [Q-008], [I-040], [P-009], [B-016], [O-005], [I-035], [P-008]

CYTOTOXICITY;     [J-030]


Dtop

D-GLUCANS     [H-015]

DANSYLGLYCINE     [L-016]

DAPI     [E-020]

DE NOVO DESIGN     [C-014]

DECIPHERING     [SP-11 - 2]

DECOLORIZATION     [J-034]

DEFENSE RESPONSE     [F-010]

DEFENSIN     [R-001], [E-010]

DEGRADATION     [SP-11 - 4]

DEHYDRATION     [F-015]

DEINOCOCCUS     [M-035]

DEMENTIA     [J-070], [J-069]

DENDRITIC CELLS     [SP-24 - 1], [T-023]

DENGUE     [S-018], [G-012]

DENTAL IMPLANTS     [BM-03]

DENTAL PULP STEM CELLS     [BM-01]

DENV2 NS5 PROTEIN     [G-011]

DERMATAN SULFATE     [M-004]

DERMATOPHYTOSIS     [F-012]

DETOXIFICATION     [E-048]

DFT     [C-020]

DHP AND DPPC     [A-011]

DIABETES MELLITUS     [BM-06]

DIABETIC CARDIOMYOPATHY     [J-004], [N-007], [U-003]

DIAGNOSIS     [J-003], [G-015], [J-056]

DICAFFEOYLQUINIC ACID     [F-016]

DICER     [SP-15 - 3], [I-028]

DIELECTRIC RELAXATION SPECTROSCOPY     [A-013]

DIETARY RESTRICTION     [SP-15 - 3]

DIFFICULT-TO-TRANSFECT CELLS     [SP-09 - 2]

DIFLUBENZURON     [L-017]

DIGESTION     [E-022]

DIGESTIVE ENZYMES     [L-014]

DIMERIZATION     [R-023]

DIOCLEA VIOLACEA     [L-003]

DIOCLEA WILSONII     [F-025]

DISEASES     [SP-08 - 4], [SP-02 - 4]

DISINFESTATION     [J-060]

DISINTEGRIN     [J-063]

DISORDER     [SP-04 - 3]

DISORDERED     [SP-05 - 1]

DISORDERS     [SP-02 - 3]

DITYROSINE CROSS-LINK     [T-008]

DIVERSITY     [SP-07 - 4]

DNA DAMAGE RESPONSE     [N-018]

DNA METHYLATION     [SP-18 - 2]

DNA REPAIR     [CF-5]

DNA REPAIR PROTEINS     [SP-10 - 2]

DNMT2     [SP-18 - 2]

DOCKING     [O-003]

DOPAMINERGIC SYSTEM     [P-016]

DOXAZOSIN     [B-033]

DPPC     [V-009]

DPPH     [F-041]

DROPOUT     [K-011]

DROSOPHILA     [I-038]

DRUG     [H-006]

DRUG DESIGN     [C-025]

DRUG DISCOVERY     [P-017]

DRUG TARGET DISCOVERY     [M-029]

DRUMMOND     [E-020]

DSRNA VIRUSES     [G-016]

DUAL OXIDASE EVOLUTION     [N-010]

DYNAMICS     [M-007]

DYSKINESIA     [P-011]

DYSLIPIDEMIA     [J-069], [BM-04]


Etop

ECTATOMMA OPACIVENTRE     [J-046]

EDUCATIONAL GAME     [K-014]

EDUCATIONAL GAMES     [K-007], [K-001]

EIF5A     [I-014]

ELECTROPORATION IN EGGS     [E-021]

ELEMENT DISTRIBUTION     [O-020]

ELICITATION     [O-040]

ELICITOR     [F-010]

EMBRYOGENESIS     [E-038]

EMPIRICAL SCORING FUNCTIONS     [C-005]

EMT     [S-008], [SP-20 - 1], [O-013]

ENADE     [K-003]

ENANTIOSELECTIVITY     [J-022]

END-STAGE RENAL DISEASE     [D-020], [D-009]

ENDOCRINE DISRUPTORS     [I-007]

ENDOCYTOSIS     [E-027], [E-022], [SP-14 - 4], [A-040]

ENDOPHYTIC FUNGI     [H-005]

ENDOSYMBIONTS BACTERIA     [E-016]

ENDOTHELIAL     [M-023]

ENDOTHELIAL CELLS     [J-023]

ENDOTHELIAL DYSFUNCTION     [D-026]

ENERGY METABOLISM     [A-026], [A-009]

ENPP1     [BM-02]

ENTEROCYTES     [D-027]

ENTOMOPATHOGENIC FUNGI     [N-019]

ENVIRONMENTAL     [SP-07 - 3]

ENVIRONMENTAL FACTORS     [I-001]

ENZYMATIC KINETIC     [L-006]

ENZYMATIC SYNTHESIS     [J-059]

ENZYME     [M-002]

ENZYMES     [J-016], [SP-16 - 1]

EPIDERMAL GROWTH FACTOR RECEPTOR     [O-012]

EPIGENETICS     [SP-18 - 4], [SP-24 - 4], [CF-5]

EPITHELIAL     [SP-02 - 2]

EPITHELIAL TO MESENCHYMAL TRANSITION     [S-017]

EPOXIDE HYDROLASE     [J-022]

ERECTION     [R-004]

ERK     [B-011]

ERYTHRINA POEPPIGIANA     [J-011]

ERYTHROCYTES     [A-016]

ESSENTIAL OIL     [J-037]

ESTRIOL     [B-034]

ESTROGEN     [J-044]

ETHANOL     [L-030]

ETHICAL VIOLATIONS     [SP-19 - 1]

EUGENOL     [P-008]

EUKARYOTIC SSU RNA     [H-016]

EUTERPE OLERACEA MART.     [D-022]

EVOLUTION     [N-018]

EVOLVING NORMS/BIOINFORMATICS TOOLS     [SP-19 - 3]

EXCITOTOXICITY     [SP-01 - 4]

EXCRETION     [E-048]

EXERCISE     [A-038], [I-009], [Q-006]

EXOSSOME     [SP-08 - 4]

EXPRESSION     [E-014]

EXPRESSION LEVEL     [J-021]

EXPRESSION MICROARRAYS     [SP-18 - 3]

EXPRESSION SYSTEM     [J-044]

EXPRESSION SYSTEMS     [J-055]

EXTRACELLULAR MATRIX     [B-040], [S-019], [N-011]

EXTRACELLULAR MATRIX REMODELING     [BM-01]

EXTREMOPHILE     [M-035]


Ftop

FACTOR XIA     [M-042]

FACTORIAL DESIGN     [L-008]

FAM3B     [D-016]

FAM3B/PANDER;     [I-037]

FAMILIAL HYPERCHOLESTEROLEMIA     [A-027]

FAPERJ     [G-020]

FASCIOLA HEPATICA     [S-015]

FATP     [E-002]

FATTY ACID ELONGASES     [E-037]

FATTY ACIDS     [G-021]

FBXO25     [B-011]

FCN3     [I-019]

FERMENTATION     [J-047]

FETAL DEVELOPMENT     [T-016]

FIBRINOGEN     [E-041]

FIBRINOPEPTIDE A     [R-024]

FICUS BENJAMINA     [F-019]

FILM     [J-037]

FILMS     [O-015]

FISH     [M-018]

FISH OIL     [P-003]

FITC     [M-039]

FLAVONES     [T-020]

FLAVONOID     [T-025]

FLAXSEED OIL     [T-030]

FLOW CYTOMETRY     [J-013], [P-021], [H-002]

FLOWERING     [F-013]

FLUCTUATION SPECTROSCOPY     [SP-06 - 1]

FLUORESCENCE     [V-004], [L-016]

FLUORESCENCE LIFETIME MICROSCOPY     [G-008]

FLUORESCENCE MICROSCOPY     [T-019]

FLUORESCENT     [SP-06 - 2]

FLUORIDE     [BM-01]

FOAM NEST     [S-002]

FOLK MEDICINE     [F-023]

FOLLICULAR ATRESIA     [E-028]

FOOD     [T-014]

FOOD FREQUENCY QUESTIONNAIRE     [M-041]

FOOD RESTRICTION     [T-015]

FOOD SAFETY     [F-018], [I-032]

FORCE FIELD PARAMETERS     [C-016]

FORIZONTAL GENE TRANSFER     [N-019]

FRACTIONAL FACTORIAL DESIGN     [J-001]

FREE RADICALS     [K-013]

FRIESINGER SCORE     [D-007], [D-008]

FRUCTOSE-RICH DIET     [D-022]

FRUIT     [J-067]

FRUITS     [T-014]

FRUTALIN     [M-017], [M-007]

FUCAN     [O-017]

FUCOIDAN     [O-035], [SP-13 - 3], [V-003]

FUCOSYLTRANSFERASE     [O-010]

FULLY-FOLDED LOCALLY-UNFOLDED TRANSITION     [C-004]

FUNCTIONAL ASSAY     [I-026], [I-004]

FUNCTIONAL CHARACTERIZATION     [F-044]

FUNCTIONAL FOODS     [SP-12 - 4]

FUNCTIONING     [SP-07 - 3]

FUNGI     [CF-1]

FUNGOS FILAMENTOSOS     [J-065]

FUNGUS     [J-023]

FUSARIUM     [R-021]

FUSARIUM OXYSPORUM     [O-040]

FXIA     [SP-14 - 1]


Gtop

G-CSF     [J-004]

GALACTAN     [I-030]

GALACTOFURANOSE     [SP-13 - 4]

GALACTOMANAN     [J-014]

GALACTOMANNAN     [O-014], [J-061]

GALACTOMANNANS     [A-031]

GALACTOSIDES     [O-003]

GALECTIN-1     [O-003]

GALECTIN-3     [D-004], [D-024], [D-003]

GALLERIA MELLONELLA     [SP-12 - 2]

GAME     [K-010]

GAMIFICATION     [K-001]

GASTRECTOMY SURGERY     [N-013]

GENE     [N-012]

GENE DELIVERY     [SP-09 - 2]

GENE DUPLICATION     [N-010]

GENE EXPRESSION     [B-031]

GENE REARRANGEMENT     [I-013]

GENERATING ISSUES     [K-009]

GENETIC PREDISPOSITION     [N-016]

GENETIC VARIABILITY     [H-001]

GENETICS     [BM-06]

GENOMIC ANALYSIS     [N-007]

GENOMIC BIOMARKERS IN HUMAN CANCER     [SP-02 - 1]

GENOMIC DNA     [F-025]

GENOMICS     [SP-07 - 3]

GERMINABILITY     [F-007]

GERMINATION     [R-019]

GESTATIONAL DIABETES     [M-041], [B-034]

GH 18 CHITINASE D-LIKE     [N-019]

GIARDIA     [B-006]

GILL (NA+, K+)-ATPASE     [L-010]

GLICOCONJUGADOS     [B-018]

GLIFOSATO     [I-007]

GLIOBLASTOMA     [A-039], [I-008]

GLIOMAS     [Q-008]

GLIOMAS CELLS     [P-001]

GLND     [G-006]

GLOSSOSCOLEX PAULISTUS HEMOGLOBIN     [M-022], [M-039]

GLUCANS     [O-034]

GLUCOMANNAN     [H-011]

GLUCOSE     [R-032]

GLUCOSIDASE INHIBITORS     [J-049]

GLUCOSYLCERAMIDE     [H-008]

GLUTAMATE     [A-024]

GLUTAMATE EXCITOTOXICITY     [Q-003]

GLUTATHIONE S-TRANSFERASE     [E-040], [E-025]

GLYCAN     [C-006]

GLYCATION     [BM-04]

GLYCEMIA     [K-004]

GLYCOGEN METABOLISM     [E-019]

GLYCOLIPIDS     [SP-13 - 5]

GLYCOPROTEIN     [C-006]

GLYCOSAMINOGLYCANS     [O-041], [SP-13 - 5]

GLYCOSIDASES     [SP-16 - 1], [E-006]

GLYCOSYLATION     [SP-17 - 4], [O-025]

GLYCOSYLTRANSFERASE     [M-005]

GLYOXYLATE PATHWAY     [A-028]

GLYPHOSATE     [A-007]

GLYPICANS     [O-027]

GOLD TREE     [R-002]

GOLDEN SHOWER TREE     [F-001]

GONIOPSIS CRUENTATA     [L-024]

GOOD SCIENTIFIC     [SP-19 - 2]

GREEN SEAWEED     [O-032]

GROMOS     [C-025]

GSK3     [E-018]

GUAIACOL PEROXIDASE     [J-058]

GUANOSINE     [A-024]

GUARANA (PAULLINIA CUPANA)     [T-004]

GUT BACTERIAL DIVERSITY     [N-013]

GUT MICROBIOTA     [J-012]

GYRASE     [R-015]


Htop

H+-ATPASE     [SP-21 - 4]

H+-ATPASES     [A-006]

H+-PYROPHOSPHATASES     [A-004]

H. PYLORI     [T-001]

H2O2 RESISTANCE     [E-005]

HADRUROIDES LUNATUS     [R-016]

HAEMOCYANIN     [SP-22 - 3]

HAPATITIS C VIRUS     [J-006]

HAS-MIR-1.     [D-002]

HBP     [O-013]

HCV     [G-001]

HEALTHSPAN     [T-031]

HEAT STRESS     [N-015]

HEK293 CELLS     [A-029]

HEMAGGLUTININ     [F-005], [R-007], [R-002], [F-003], [F-001], [F-039], [R-030]

HEMAQGLUTININ     [F-022]

HEME     [E-008], [J-012], [E-012], [S-011]

HEME BIOCRYSTALLIZATION     [E-006]

HEMICELLULOSE     [E-030]

HEMOLYMPH     [S-001], [R-028]

HEMOLYMPH AND MIDGUT     [E-032]

HEMOLYSIS     [F-031]

HEMOLYSIS.     [J-030]

HEMOPROTEIN     [M-034]

HEMOSTASIS     [M-043]

HEMOZOIN     [E-012], [E-006]

HEPARAN     [SP-17 - 1]

HEPARAN SULFATE     [R-035]

HEPARIN     [O-002], [J-019], [M-042]

HEPARIN ANALOGS     [SP-17 - 3]

HEPATIC STELLATE CELLS     [B-007], [B-032], [B-008]

HEPATITIS C VIRUS     [G-019], [M-009]

HEPATOCELLULAR CARCINOMA     [D-025]

HEPATOTOXICITY     [T-018]

HEPG2 CELLS     [A-030], [P-021]

HERBASPIRILLUM SEROPEDICAE     [G-006], [G-014]

HERBICIDE     [A-014]

HERBIVORY ON AGRICULTURAL PESTS     [E-016]

HEREDITARY HEMOCHROMATOSIS     [I-002]

HESPERITIN     [C-001]

HETEROFUCAN     [O-022], [O-004]

HETEROLOGOUS EXPRESSION     [M-005], [M-021]

HEXANE EXTRACT     [F-031]

HEXOKINASE     [E-038], [A-021]

HEXOSES     [U-002]

HIDRAZONES     [P-001]

HIGH FAT DIET (HFD)     [A-012]

HIGH HYDROSTATIC PRESSURE     [M-036]

HIGH-SALT DIET     [T-005]

HIGH-TEMPERATURE STRESS     [F-044]

HIPERGLYCEMIA     [A-036]

HISTONE METHYLATION DEMETHYLATION     [H-006]

HIV     [I-003]

HIV-1     [N-003], [N-004]

HMGB1     [I-025], [G-011]

HOMEOSTASIS     [CF-3]

HOMOLOGY MODELING     [U-002]

HORMONES     [F-029]

HORSERADISH POX     [J-058]

HORSES     [H-021]

HOST-PARASITE INTERACTION     [D-004], [D-003]

HRASV12     [B-026]

HTLV-1     [G-003]

HUMAN BRAIN     [Q-017]

HUMAN BREAST CANCER CELL     [B-014]

HUMAN CANCER     [SP-02 - 1]

HUMAN HSP27     [H-009]

HUMAN IPS     [J-004]

HUMAN PERIODONTAL LIGAMENT (PDL).     [BM-05]

HUMIDITY CONTROL     [F-007]

HYALURONIDASE-LIKE ENZYME     [SP-22 - 2]

HYBRID COATINGS     [V-007]

HYBRID MATERIALS     [V-005]

HYDRATION     [A-013]

HYDRIC STRESS     [L-014]

HYDROGEL     [J-061]

HYDROGEN PEROXIDE     [E-019]

HYDROGEN SULFIDE     [SP-09 - 1]

HYDROXYAPATITE     [V-005], [V-010]

HYDROXYCINNAMIC ACIDS     [T-009]

HYPERCHOLESTEROLEMIC DIET     [D-023]

HYPERFERRITINEMIA     [I-002]

HYPERGLYCEMIA     [A-009], [O-025]

HYPERTENSIVE CRISIS     [D-026]

HYPERTHYROIDISM     [A-034]

HYPOGLYCEMIC EFFECT     [F-020]

HYPOTENSIN     [R-033]

HYPOTHYROIDISM     [D-014]

HYPOXIA     [A-035]


Itop

IAP     [D-024]

IFRJ     [G-020]

IGF1R/IRS     [SP-20 - 2], [P-014]

IL32     [SP-20 - 4]

ILEX PARAGUARIENSIS     [F-014]

IMMUNE RESPONSE     [O-007]

IMMUNITY     [D-011]

IMMUNODIAGNOSIS     [J-033]

IMMUNOSUPPRESSION     [D-009]

IMMUNOSUPPRESSIVE     [I-030]

IMNV     [G-016]

IMOBILIZATION     [SP-16 - 1]

IMPORTIN     [SP-10 - 1]

IMPORTIN-     [SP-10 - 3]

IMPORTIN-α     [SP-10 - 2]

IMUNOMODULATORY     [O-023]

IN SILICO     [C-028]

IN VITRO DIGESTION     [P-012]

IN VIVO     [O-006]

INCLUSION BODIES     [J-051]

INCREASES     [SP-01 - 4]

INDEL     [I-034]

INDUCED CIRCULAR DICHROISM     [M-015]

INDUCED PLANT VOLATILES     [F-043]

INFECTION     [H-021]

INFECTIOUS     [SP-02 - 4]

INFLAMMASOME     [Q-015]

INFLAMMATION     [SP-23 - 3], [D-014], [SP-05 - 3], [P-006], [F-023]

INFLUENZA     [G-009]

INGA EDULIS     [J-054]

INHIBITION OF MELANOGENESIS     [T-024]

INHIBITOR     [C-014]

INHIBITORS     [G-004], [SP-16 - 2]

INHIBITORS OF PEPTIDASES     [J-011]

INORGANIC PHOSPHATE TRANSPORT     [H-010], [B-017]

INORGANIC POLYPHOSPHATE     [E-024], [A-022]

INOSITOLMONOPHOSPHATASE 2 (IMPASE 2)     [C-001]

INSECT     [E-030], [E-022], [R-028], [E-024]

INSECT-PLANT INTERACTION     [E-001]

INSECTICIDE     [E-042]

INSECTICIDE RESISTANCE     [N-009]

INSULIN     [A-034]

INSULIN RECEPTOR SUBSTRATE     [P-022]

INSULIN RESISTANCE     [SP-15 - 2], [SP-15 - 4]

INSULIN-LIKE GROWTH FACTOR 1     [BM-04]

INTEGRIN     [C-014]

INTERACTION PROTEIN AND SURFACTANT     [M-034]

INTERACTIVE TUTORIALS     [K-012]

INTERAÇAO CELULA HOSPEDEIRO     [B-018]

INTERLEUKIN-10     [B-008]

INTERLEUKIN-6     [B-008]

INTESTINAL INFECTION     [J-052]

INTRACELLULAR TRAFFICKING     [A-040]

INTRINSIC AND EXTRINSIC MOTIVATION     [K-006]

ION CHANNEL MODULATOR     [SP-22 - 1]

ION SIGNALS     [SP-21 - 3]

IONIC HOMEOSTASIS     [F-021]

IONIC LIQUID     [C-011]

IRON BINDING     [M-010]

IRON-SULFU     [SP-03 - 3]

ISCHEMIC PRECONDITIONING     [S-009]

ISOMERISM     [K-009]

ITGB1     [S-008]


Jtop

JABUTICABA     [D-010]

JAK-STAT     [B-035]

JAK/STAT     [CF-3]

JAMBO     [T-002]

JUVENILE IDIOPATHIC ARTHRITIS     [I-012]


Ktop

K. PNEUMONIAE     [J-031]

KALA-AZAR     [F-022], [F-003], [F-001], [F-039], [R-030], [F-005], [R-007], [R-002]

KALLIKREIN, KININ     [SP-14 - 2]

KAVA KAVA     [P-007]

KERATINOCYTE     [B-026]

KERATINOCYTE DIFFERENTIATION     [B-039]

KIDNEY     [U-001]

KIDNEY STONE     [O-036]

KIDNEY TRANSPLANTATION     [BM-03]

KILLER YEAST     [J-025]

KINASES     [F-030]

KLEBSIELLA PNEUMONIAE     [N-005]

KLUYVEROMYCES MARXIANUS     [J-025]

KRAS     [I-039]

KREBS CYCLE     [A-008]

KUNITZ     [R-029]


Ltop

L-ASPARAGINASE     [L-022]

L-GLUTAMINASE     [L-008]

L. CHAGASI     [D-005]

L. INFANTUM     [F-002]

LABILE IRON POOL     [T-006]

LACTATE     [A-033]

LACTATION     [A-003]

LACTOBACILLUS SP     [D-015]

LACZ     [J-042]

LANGMUIR BLODGETT     [V-006]

LANGMUIR MONOLAYERS     [A-011], [V-008]

LANTPDASE-1     [H-018]

LARVAL THERAPY     [R-013]

LARVICIDE     [SP-05 - 4]

LATEX     [F-037], [U-001]

LATICIFER PROTEINS     [F-036]

LAUNDRY DETERGENTS     [SP-16 - 3]

LAURIC ACID     [A-044]

LEARNING ANALYTICS     [K-002]

LEARNING AND MEMORY     [Q-007]

LEARNING OBJECT     [K-004]

LECTIN     [R-021], [S-003], [L-003], [O-038], [R-011], [M-040], [B-030], [R-034], [M-018], [Q-001]

LECTINS     [F-025]

LEISHMANIA     [I-040], [H-012], [O-005], [SP-24 - 1], [SP-18 - 4], [I-003], [H-003]

LEISHMANIA (L.) AMAZONENSIS     [B-031]

LEISHMANIA (LEISHMANIA) AMAZONENSIS     [B-015]

LEISHMANIA BRAZILIENSIS     [T-007]

LEISHMANIA INFANTUM     [N-017]

LEISHMANIA MEXICANA     [E-008]

LEISHMANIASIS     [T-013], [SP-24 - 2], [T-023], [H-018]

LEPIDOPTERA     [S-001]

LEPROSY     [A-033], [D-013], [I-019], [B-005]

LEPTIN     [D-005]

LEPTINOTARSA DECEMLINEATA     [E-017]

LETHAL FACTOR     [J-029]

LEUCOAGARICUS GONGYLOPHORUS     [L-013]

LEUKEMIA     [N-002], [P-026], [SP-20 - 4], [A-018], [P-024]

LEVODOPA     [P-011]

LIFETIME     [SP-06 - 2], [M-039]

LIGNINA     [J-065]

LINEAR RESPONSE THEORY     [C-029]

LIPASE     [E-014]

LIPASES     [L-004]

LIPID DROPLET     [S-018]

LIPID LEVEL     [I-022]

LIPID RAFTS     [E-015]

LIPID TRANSFER PROTEIN     [F-035]

LIPIDS     [T-021], [J-035], [D-014]

LIPOFUSCIN     [T-028]

LIPOPEPTIDE     [J-001]

LIPOPOLYSACCHARIDE     [G-005]

LIPOSOMES     [A-044]

LIPOSSOMOS     [L-009]

LIPOXIN     [P-006]

LIQUID CHROMATOGRAPHY     [I-021]

LIVE VECTOR VACCINE     [SP-24 - 3]

LIVER     [A-043]

LIVER FIBROSIS     [I-025], [B-007]

LIVER TOXICITY     [A-041]

LLO     [C-007]

LOCOMOTOR BEHAVIOR     [T-031]

LONGEVITY     [H-009]

LONOMIA OBLIQUA     [E-032]

LOPHIOSURUS ALEXANDRI     [A-023]

LOXOSCELES     [R-006]

LUCIFERASE     [K-005]

LUCIFERASE-LIKE ENZYMES     [E-048]

LUCIFERASES     [M-026]

LUETZELBURGIA AURICULATA     [F-033]

LUGDUNENSIS     [G-002]

LUNATIN 1     [R-016]

LUTZOMYIA LONGIPALPIS     [E-008]

LUV     [A-044]

LYCOPENE     [B-002]

LYTECHINUS VARIEGATUS     [J-024]


Mtop

MACROALGAE     [I-022]

MACROBRACHIUM AMAZONICUM     [L-010]

MACROMOLECULES     [SP-02 - 5]

MACROPHAGE     [T-013], [T-003]

MACROPHAGES     [O-014], [B-019], [F-002]

MAGAININ 2     [R-023]

MAGAININ I     [S-021]

MAGNETIC PARTICLES     [L-027]

MALARIA     [R-022], [U-002]

MALIGNANT TRANSFORMATION     [T-028]

MALNUTRITION     [I-018]

MAMMALS     [SP-10 - 4]

MANGROVE CRAB     [L-011], [L-024]

MANGROVE CRAB,     [L-025]

MANNAN     [O-028]

MAPK     [BM-01]

MAPLE SYRUP URINE DISEASE     [Q-005]

MARINE     [SP-07 - 4], [SP-07 - 1]

MARINE BIOMOLECULES     [O-004]

MARINE ORGANISMS     [SP-13 - 2]

MASP1     [I-019]

MASS SPECTROMETRY     [J-066], [F-030], [S-016], [S-007]

MASTOPARAN     [C-010]

MATRIX VESICLE     [BML-01]

MATRIX VESICLES     [BM-02]

MB-PDT     [B-012]

MC3T3-E1     [O-002]

MD     [M-003]

MDA-MB-231     [B-017], [D-016]

MDPC-23 CELLS     [B-013]

MECHANICAL     [SP-03 - 3]

MECHANISM     [SP-03 - 1]

MECHANISM OF ACTION     [P-001], [R-022]

MECHANISMS     [SP-01 - 3]

MEDICINAL PLANTS     [F-009], [U-001]

MEDULLOBLASTOMA     [S-007]

MEGAKARYOCYTE     [G-010], [B-022]

MELANOMA     [O-024], [P-024], [M-033], [B-038], [P-017]

MELANOMA CELLS     [A-019]

MEMBRANE     [SP-01 - 2]

MEMBRANE PROTEIN     [M-013]

MEMBRANE PROTEINS     [M-025]

MESENCHYMAL STEM CELL     [I-005], [I-006]

MESENCHYMAL STEM CELLS     [U-003], [B-039]

MESOIONIC COMPOUNDS     [SP-12 - 1]

METABOLIC     [SP-11 - 2]

METABOLIC IMPRINT     [A-003]

METABOLIC OBESE NORMAL WEIGHT     [D-021]

METABOLIC PROFILE     [A-020]

METABOLIC PROGRAMMING     [T-005], [T-025], [T-015]

METABOLIC SYNDROME     [T-030]

METABOLISM     [A-030], [A-037], [A-007], [K-010], [E-034], [SP-17 - 4], [E-018], [G-012], [A-018]

METABOLISM SCHWANN CELLS     [A-033]

METABOLISMO OF PURINES     [L-021]

METABOLITES     [SP-07 - 2]

METABOLOMICS     [A-028], [J-035]

METABOLOMICS AND TRANSCRIPTOMICS     [F-006]

METAGENOME     [J-051], [C-021], [M-005]

METAGENOMIC     [J-039]

METAL CHELATION     [O-034]

METAL COMPLEX     [P-009]

METAL CONTAMINATION     [I-011]

METAL HOMEOSTASIS     [SP-12 - 3]

METAL REMOVAL     [J-040]

METALLOENZYMES     [M-038]

METALLOPROTEIN     [SP-03 - 1]

METASTASIS     [SP-17 - 3]

METASTATIC CELL MIGRATION     [SP-09 - ]

METASTATIC PHENOTYPE     [A-020]

METAZOAN     [SP-16 - 2]

METFORMIN     [P-005], [T-011]

METHANOLIC EXTRACTS     [I-035]

METHOD     [S-016]

METHODS     [SP-03 - 2]

METHYLMERCURY     [T-022]

METHYLPHENIDATE     [Q-009]

METILTRANSFERASE     [E-013]

MICRO     [CF-7]

MICROALGAE     [J-007], [J-005]

MICROBIAL RESISTANCE     [B-001]

MICROBIOTA     [N-001]

MICROGRAMMA VACCINIIFOLIA     [R-021]

MICROORGANISMS     [SP-07 - 2], [J-016]

MICROPROCESSORS     [SP-02 - 5]

MICRORGANISMS     [J-060]

MICRORNAS     [I-039]

MICROSATELLITE POLYMORPHISM     [H-001]

MICROSCOPY     [E-005], [SP-06 - 1]

MIGRATION     [O-024]

MILD HYPERHOMOCYSTEINEMIA     [T-026]

MIMOSA REGNELLII     [M-033]

MINERALIZATION     [BM-01], [B-009]

MIRNA     [F-013], [I-024]

MISCONCEPTIONS     [K-013]

MITOCHONDRIA     [I-029], [A-022], [E-024], [A-020], [A-010], [A-036], [D-018], [A-014], [A-021], [A-043], [A-038], [A-039], [B-025], [D-017], [CF-1], [SP-15 - 1]

MITOCHONDRIA PERMEABILITY TRANSITION-MPT     [A-041]

MITOCHONDRIAL     [SP-01 - 3], [SP-01 - 1], [SP-01 - 2], [SP-01 - 4]

MITOCHONDRIAL BIOENERGETIC     [A-023]

MITOCHONDRIAL BIOENERGETICS     [SP-12 - 1], [A-015], [A-017]

MITOCHONDRIAL CALCIUM UNIPORTER     [H-004]

MITOCHONDRIAL ELECTRON TRANSPORT SYSTEM     [A-042]

MITOCHONDRIAL FISSION     [A-025]

MITOCHONDRIAL FUNCTION     [SP-15 - 4]

MITOCHONDRIAL FUNCTIONS     [A-031]

MMP     [BM-04]

MMPS     [U-001]

MODELING     [M-007]

MODULATORS     [J-055]

MOFUMBO     [F-039]

MOLECULAR AND NON-MOLECULAR ANALYSES     [V-002]

MOLECULAR BIOLOGY     [N-002]

MOLECULAR BIOMARKERS     [J-026], [J-048]

MOLECULAR DIAGNOSIS     [I-002]

MOLECULAR DOCKING     [C-022], [C-024]

MOLECULAR DYNAMIC     [C-009]

MOLECULAR DYNAMICS     [H-003], [C-028], [C-017], [C-023], [R-022], [C-003], [C-016], [C-029], [C-007], [C-013], [C-026], [C-011], [C-025], [C-012]

MOLECULAR MARKER     [D-001]

MOLECULAR MODEL     [M-021]

MOOCS     [K-002]

MORINDA CITRIFOLIA L.     [F-035]

MORINGA     [F-034]

MORINGA OLEIFERA     [F-020], [T-016], [R-034], [F-012], [R-012], [J-040], [R-011]

MORPHOGENETIC TRANSITION     [A-006]

MORPHOLOGY     [H-014]

MORTALITY     [F-029]

MOTILITY     [CF-2]

MPP+     [Q-014]

MRNA     [SP-10 - 4]

MUCOR SUBTILISSIMUS     [L-023]

MUCUS     [M-018]

MULTI-TEST PLATFORM     [I-032]

MULTIDOMAIN CONFORMATIONAL SELECTION     [M-006]

MULTIEPITOPE     [G-015]

MULTIEPITOPE PROTEIN     [J-003]

MULTIPLE     [SP-25 - 3]

MULTIPLE REACTION MONITORING (MRM)     [S-006]

MULTIRESISTANT BACTERIA     [R-026]

MUSCLE     [A-038]

MUTAGENICITY     [T-027]

MUTATIONS     [N-003]

MYCOBACTERIUM LEPRAE     [B-005]

MYCOBACTERIUM TUBERCULOSIS     [L-018]

MYELODYSPLASTIC SYNDROMES     [B-036]

MYELOPEROXIDASE     [L-016]

MYELOPROLIFERATIVE NEOPLASMS     [P-005], [SP-20 - 2]

MYOSIN     [CF-2]


Ntop

N-GLYCANS     [SP-17 - 2]

N-GLYCOSYLATION     [L-002], [SP-20 - 1], [C-017], [C-007]

NA+/CA2+ EXCHANGER     [M-025]

NA+/CA2+ EXCHANGERS     [M-012]

NA,K-ATPASE     [L-020], [M-013], [L-009]

NAD METABOLISM     [A-005]

NAFLD     [D-023], [D-010]

NANOCOMPLEXES     [SP-09 - 2]

NANODEVICES     [SP-25 - 3]

NANOLIPOSOMES     [B-002]

NANOPARTICLES     [J-050]

NANOTECHNOLOGY     [J-041], [O-019]

NANOTOPOGRAPHY     [BM-05]

NAPHTHOQUINONES     [P-015]

NATURAL PRODUCTS     [L-018], [E-020], [F-038]

NDT1 PROTEIN     [A-029]

NEGLECTED DISEASES     [A-002]

NEMATODE     [T-010]

NEOPTERIN     [Q-015], [Q-007]

NEPHROLITH     [O-004]

NEROL     [P-024]

NERVE GROWTH FATOR     [Q-005]

NERVOUS SYSTEM     [E-042]

NETWORK     [SP-16 - 4]

NEUROBLASTOMA     [B-033], [P-003]

NEURODEGENERAÇAO     [T-004]

NEURODEGENERATION     [T-010], [T-031]

NEURODEGENERATIVE     [SP-08 - 4]

NEUROIMMUNE     [SP-04 - 3]

NEUROINFLAMMATION     [SP-08 - 1], [Q-007]

NEUROINNFLAMMATION     [Q-006]

NEUROLOGICAL DISEASE     [SP-04 - 4]

NEUROLOGICAL HEALTH     [SP-04 - 4]

NEUROPATHOLOGY     [Q-017]

NEUROPROTECTION     [Q-003], [Q-016], [SP-09 - 5]

NEUROPROTEOMICS     [SP-02 - 3]

NEUROTOXICITY     [Q-001]

NEUROTROPHINS     [Q-013], [Q-009]

NEUTRON ACTIVATION     [I-008]

NEUTROPHIL ACTIVITY     [R-020]

NEUTROPHIL EXTRACELLULAR TRAPS     [D-011]

NEUTROPHIL STATE OF ACTIVATON     [SP-24 - 1]

NEW-ONSET AF     [I-024]

NEXT-GENERATION SEQUENCING     [N-008]

NF-κB     [P-019]

NF-KAPPAB     [SP-18 - 4]

NFAT     [Q-010]

NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE     [A-012]

NILE RED     [J-013]

NIR     [T-019]

NITRATION     [N-011]

NITRIC OXIDE     [B-038], [O-002], [O-016]

NITRITE REDUCTASE     [M-011]

NITROGEN FIXATION     [G-005]

NITROGEN SOURCE     [F-021], [F-017]

NITRONES     [P-020]

NMR     [O-041], [M-012]

NMR SPECTROSCOPY     [SP-13 - 1], [SP-13 - 5]

NMR-BASED METABOLOMICS     [D-006]

NO PRODUCTION     [O-014]

NORMAL MODES     [C-009]

NOS     [A-002]

NOVEL FOODS     [J-057]

NRF2.     [T-013]

NS1     [G-012]

NS5A     [G-001]

NT157     [SP-20 - 2], [P-014]

NTPDASE-1     [H-018]

NUCLEAR IMPORT     [SP-10 - 3]

NUCLEAR LOCALIZATION SIGNAL (NLS)     [SP-10 - 1]

NUCLEAR MAGNETIC RESSONANCE     [M-037]

NUCLEAR TRANSPORT     [SP-10 - 2]

NUCLEASE     [J-038]

NUCLEATION CORE     [BM-02]

NUCLEIC     [SP-03 - 2]

NUCLEOTIDE BINDING DOMAIN     [M-030]

NUTRITION     [T-015]

NUTRITIONAL ASSESSMENT     [D-020]


Otop

O-GLCNAC     [O-011], [O-013]

O-GLCNACYLATION     [O-024]

OBESITY     [R-031], [A-003], [BM-05], [D-021]

ODONTOBLAST     [B-013]

ODORANT RECEPTOR     [E-045]

ODORANT-BINDING PROTEINS     [E-044]

OLIGOMERIC STABILITY     [M-022]

OLIGOMERIZATION     [M-013]

OLIGOSACCHARYLTRANSFERASES     [C-017]

OMEGA 3     [A-008]

OMEGA-3     [A-014], [A-026]

ORAL CANCER     [B-037]

ORGANIC EXTRACTS     [F-026]

ORGANIC LAYER     [J-008]

ORGANOTYPIC CULTURE     [Q-017]

ORIGIN     [G-003]

OSMOPRIMING     [F-027]

OSSEOINTEGRATION     [BM-03]

OSTEOBLAST     [B-009], [BML-01], [B-020], [BM-01], [B-021]

OSTEOBLASTS     [V-007], [BM-05], [BM-01]

OSTEOCLASTS     [BM-03]

OSTEOINDUCTIVE EFFECT     [O-033]

OSTEOPOROSIS     [BM-01]

OVARIAN CANCER     [S-017], [S-006]

OVARIECTOMIZED     [J-068]

OVER EXPRESSION     [M-011]

OXIDASES     [J-065]

OXIDATION     [T-006]

OXIDATIVE BURST     [T-001]

OXIDATIVE DAMAGE     [T-030]

OXIDATIVE METABOLISM     [J-058]

OXIDATIVE PHOSPHORYLATION     [A-042]

OXIDATIVE STRESS     [D-017], [A-015], [Q-014], [T-011], [A-028], [T-003], [SP-23 - 3], [D-022], [C-008], [SP-12 - 4], [T-016], [C-018]

OXOVANADIUM     [A-031], [A-017]

OXYDATIVE STRESS     [B-002]

OMEGA-3     [Q-016]


Ptop

P-CHLOROANILINE     [L-017]

P. PUTIDA     [S-013]

P2Y6 RECEPTOR     [O-026]

P53     [P-023]

P53 AGGREGATION     [M-020], [D-012], [D-025]

P53 PROTEIN     [M-009]

PACKAGING     [O-029]

PALB2     [I-004]

PANCREATIC CANCER     [I-039]

PARALYSIS     [T-010]

PARASITE     [SP-16 - 2]

PARASITE LOAD     [J-062]

PARASITE-HOST INTERACTION     [S-015]

PARASITIC DISEASE     [H-021]

PARATHORMONE     [A-011]

PARKINSON'S DISEASE     [Q-002], [Q-010]

PARKINSON’S DISEASE     [P-016]

PARKINSON’S DISEASE;     [Q-014]

PARKINSON´S DISEASE     [P-011]

PASSIFLORA ALATA     [O-040]

PASSIFLORA NITIDA KUNTH     [T-024]

PATHOGENIC BACTERIA     [J-052]

PATHOGENS     [SP-25 - 2]

PATHOPHYSIOLOGY     [SP-04 - 3]

PATHWAYS     [SP-10 - 4]

PEANUT     [R-032]

PEANUT PAÇOCA     [R-008], [R-009], [R-031]

PENTOSE     [J-047]

PEPTIDASE INHIBITOR     [J-054]

PEPTIDASE INHIBITORS     [J-053]

PEPTIDE     [J-027], [I-027], [R-015]

PEPTIDE-MEMBRANE INTERACTION     [R-003]

PEPTIDES     [R-014], [SP-25 - 3], [SP-25 - 04], [SP-25 - 1]

PEPTIDOGALACTOMANNAN     [SP-13 - 4]

PEPTIDOMICS     [E-047]

PEREIRO     [F-004]

PERIODONTITIS     [N-001]

PERITONEAL MACROPHAGES     [I-030]

PERMEABILIZATION     [E-011]

PEROXIREDOXIN     [T-017]

PEROXIREDOXIN 5     [C-004]

PEROXYNITRITE     [T-017], [T-006]

PERSPECTIVE     [SP-03 - 1]

PERSULFIDES     [SP-09 - 1]

PESTICIDES     [T-027]

PETA     [CF-7]

PETITE     [A-032]

PG-AMP1     [J-010]

PGPB     [F-024], [S-014]

PHAGE DISPLAY     [R-001], [R-029], [I-027], [I-016]

PHARMACOGENOMICS     [N-014]

PHARMACOLOGICAL ACTIVITIES     [O-037]

PHARMACOLOGICAL INHIBITORS     [E-011]

PHENOLS     [T-012], [T-002]

PHENOTYPE     [BM-06]

PHENOTYPE, PROTEOMICS     [S-001]

PHENYLALANINE     [Q-004]

PHENYLKETONURIA     [Q-004], [D-018]

PHOSPHO1     [BM-02]

PHOSPHOLIPASE A2     [B-029]

PHOSPHOLIPASE A2 INHIBITOR     [B-015]

PHOSPHOLIPID     [M-019]

PHOSPHOLIPIDS     [A-016]

PHOSPHOMONOHYDROLASES     [L-006]

PHOSPHORUS     [D-027]

PHOSPHORYLATION     [B-040], [S-019], [F-030]

PHOTODYNAMIC THERAPY     [B-027], [J-041]

PHOTOLYASE     [K-012]

PHOTOSYNTHESIS     [SP-11 - 3]

PHOTOTAXIS     [CF-4]

PHYSALIS PUBESCENS     [J-072]

PHYSICAL DEPENDENCE     [J-070], [J-069]

PHYSICAL NUT     [F-027]

PHYSICAL PROPERTIES     [O-015]

PHYSICAL TRAINING     [V-001]

PHYSICOCHEMICAL PROPERTIES     [C-022]

PI     [B-006]

PICEA GLAUCA     [R-001]

PICHIA PASTORIS     [I-017]

PICHIA PASTORIS.     [L-013]

PII PROTEINS     [G-006]

PILT     [G-004]

PINEAPPLE     [F-028]

PIPTOPORUS BETULINUS     [H-015]

PKA     [B-025]

PKCα     [SP-20 - 3]

PLA2     [B-004], [B-003]

PLA2 INHIBITOR     [M-014]

PLAGIARISM DETECTION     [SP-19 - 1]

PLAGUE CONTROL     [L-012]

PLANT DEFENSE     [E-001], [F-019], [F-011], [F-036]

PLANT DEFENSIN     [R-017]

PLANT EXTRACTS     [J-008], [P-025]

PLANT-BACTERIUM INTERACTION     [G-005]

PLASMA KALLIKREIN/KININ SYSTEM     [SP-14 - 4]

PLASMA PROTEINS     [J-019]

PLASMID     [J-038]

PLASMODIUM     [H-016], [R-014]

PLATELET AGGREGATION     [M-028]

PLATELET-RICH PLASMA     [BM-03]

PLATINUM COMPLEX OF THIOSEMICARBAZONE     [I-008]

PLATYPODIUM ELEGANS     [J-053]

PNPP-19     [R-004]

POINCIANELLA PYRAMIDALLIS     [L-022]

POLIGALACTURONASE     [L-012]

POLY-3-HYDROXYBUTYRATE (PHB)     [J-013]

POLY-PROLINE     [I-014]

POLYAMINES     [A-006]

POLYDEXTROSE     [N-013]

POLYHYDROXYALKANOATES     [J-007]

POLYMORPHISM     [D-001], [N-012], [N-016]

POLYMORPHISM ON PROMOTER REGION     [I-034]

POLYMORPHISMS     [I-015]

POLYSACCHARIDE     [O-001], [H-011], [O-029], [SP-13 - 2]

POLYSACCHARIDES     [O-015]

POLYSACCHAROME     [SP-13 - 1]

POOR SOIL     [F-024]

PORCINE HEPARIN     [O-039]

PPI     [N-006]

PRACTICE CODE     [SP-19 - 2]

PRAVASTATIN     [A-027], [A-041]

PRE-MRNA SPLICING     [P-026]

PRIMA-1     [P-023], [D-012]

PRIMER DESIGNING     [H-016]

PRINCIPLES     [CF-2]

PRION     [SP-04 - 4], [M-004]

PRION CONVERSION     [M-019]

PRION PROTEIN     [D-011]

PROCESSING OF APP     [P-020]

PRODUCTION     [SP-07 - 1]

PRODUCTS     [SP-07 - 1]

PROFILIN-1     [C-019]

PROGESTERONE RECEPTOR     [B-034]

PROLIFERATION     [B-020]

PROMOTER     [J-044]

PROPERTIES     [CF-6]

PROSTATE CANCER     [M-040]

PROTEASE     [L-023], [SP-14 - 3], [M-008]

PROTEASE INHIBITOR     [E-033]

PROTEASE INHIBITORS     [SP-05 - 3]

PROTEASE-ACTIVATED RECEPTORS     [B-013]

PROTEASES     [SP-16 - 3], [H-017], [J-036]

PROTECTION     [O-006]

PROTEIN     [E-001], [M-035]

PROTEIN CORONA     [J-066]

PROTEIN DIFFUSION     [SP-06 - 1]

PROTEIN DISULFIDE ISOMERASE     [E-035]

PROTEIN ISOLATE     [J-057]

PROTEIN KINASE     [B-010], [M-029]

PROTEIN MEMBRANE     [M-012]

PROTEIN PROFILE     [H-014]

PROTEIN PURIFICATION     [J-032], [F-041], [R-017]

PROTEIN PURIFICATION AND CHARACTERIZARIO     [J-054]

PROTEIN STABILITY     [L-028]

PROTEIN STRUCTURAL NETWORK     [M-024]

PROTEIN SYNTHESIS     [I-014]

PROTEIN-PROTEIN INTERACTION.     [G-011]

PROTEINASE INHIBITOR     [SP-05 - 1]

PROTEINS     [SP-06 - 2], [SP-01 - 1], [K-007]

PROTEOGLYCAN     [SP-17 - 1]

PROTEOGLYCANS     [O-026], [SP-14 - 4], [O-027]

PROTEOLIPOSOME     [BM-02], [BM-02]

PROTEOLIPOSOMES     [V-004]

PROTEOLYSIS     [L-027]

PROTEOME     [S-018], [S-011], [S-010], [D-013]

PROTEOMICS     [S-012], [E-015], [SP-22 - 4], [S-009], [G-002]

PROTON ATPASES     [SP-21 - 3]

PROTON PUMPS     [A-004], [A-019]

PROTOTYPE     [SP-08 - 3]

PSEUDALLESCHERIA BOYDII     [H-008]

PSEUDOMONAS AERUGINOSA     [L-022]

PSYCHIATRIC     [SP-02 - 3]

PTPB INHIBITORS     [L-018]

PUNISHMENT VS EDUCATION     [SP-19 - 3]

PURIFICATION     [M-002], [L-007]

PURINERGIC SYSTEM.     [F-014]

PYRUVATE CARBOXYLASE     [SP-15 - 2]

PYRUVATE DEHYDROGENASE PHOSPHATASE     [H-013]


Qtop

QPCR     [E-002]

QUANTITATIVE REAL TIME PCR     [H-007]

QUANTUM DOTS     [O-038]

QUESTION ANALYSIS     [K-003]


Rtop

R. MICROPLUS     [E-041]

RADIORESISTANCE     [SP-20 - 1]

RASCH ANALYSIS     [K-008]

RATIONAL DESIGN     [R-027]

RCA     [J-059]

RE1-SILENCING TRANSCRIPTION FACTOR     [I-009]

REACTIVE AND DYSFUNCTIONAL GLIA     [SP-08 - 1]

REACTIVE BLACK     [J-034]

REACTIVE OXYGEN SPECIES     [A-023]

REAL TIME PCR     [J-062]

RECEPTOR NUCLEAR     [I-007]

RECOMBINANT MULTIEPITOPE PROTEIN     [J-056]

RECOMBINANT PEPTIDE     [F-018]

RECOMBINANT PROTEIN     [I-032]

RECOMBINANTS     [N-004]

RED SEAWEED     [O-036], [O-023], [F-040]

REDOX HOMEOSTASIS     [T-005], [P-013]

REDOX/ENERGY METABOLISM     [S-017]

REFERENCE GENE     [J-021]

REGENERATIVE MEDICINE     [O-033]

RENAL CYTOPROTECTION     [O-021]

RENAL FAILURE     [D-027]

RENAL MICROPERFUSION     [SP-21 - 4]

RENAL TRANSPLANT     [D-009], [D-020]

REPELLENT     [E-045]

RESEARCH INTEGRITY     [SP-19 - 4]

RESEARCH INTEGRITY OFFICE     [SP-19 - 2]

RESISTANCE     [N-003], [G-001], [G-017], [B-035], [BM-06]

RESISTANCE MECHANISMS     [J-072]

RESISTANCE TO TREATMENT     [I-013]

RESISTANT BACTERIA     [R-027]

RESPIRATION     [SP-11 - 3]

RESPONSE SURFACE METHODOLOGY     [J-002]

RESPONSIBLE CONDUCT IN RESEARCH (RCR)     [SP-19 - 3]

RESVERATROL     [M-020], [D-010]

RETINOIC ACID     [SP-20 - 3]

RGD-LIKE DOMAIN     [P-018]

RHAMNOGALACTURANAN     [O-028]

RHINOVIRUS     [G-008]

RHIPICEPHALUS APPENDICULATUS     [E-040]

RHIPICEPHALUS MICROPLUS     [E-018], [E-023], [E-036], [E-004], [SP-24 - 3]

RHIPICEPHALUS SANGUINEUS     [E-025]

RHODNIUS     [E-044]

RHODNIUS PROLIXUS     [E-043], [E-011], [E-027], [E-045], [E-012], [E-028]

RHODOPHYTA     [F-015]

RHODOPSIN     [CF-4]

RICE     [SP-10 - 3], [G-014]

RISK ASSOCIATION     [I-023]

RITUXIMAB     [C-023]

RNA INTERFERANCE     [E-029]

RNA METHYLATION     [SP-18 - 2]

RNA-SEQ     [SP-18 - 3]

RNA-SEQ ANALYSIS     [N-017]

RNAI     [E-017]

RNAI IN EMBRYOS     [E-021]

RNASEQ     [G-014]

ROOT-KNOT NEMATODE     [J-017]

ROS     [T-023], [A-021], [F-008], [A-002]

RP21     [B-028]

RT-QPCR     [F-015]

RTG2P     [H-020]

RUTHENIUM COMPLEXES     [I-040]

RUTIN     [Q-003]

RUXOLITINIB     [P-005]


Stop

S. CEREVISIAE     [T-009]

SACCHAROMYCES CEREVISIAE     [J-042], [SP-12 - 2], [H-020], [H-009], [A-032], [J-050], [T-017]

SALIVA     [SP-05 - 2]

SALT STRESS     [S-012], [F-032], [F-017]

SALVIA HISPANICA     [J-036]

SANILITY ACCLIMATION     [L-020]

SARCONESIOPSIS MAGELLANICA     [R-013]

SATIETY     [R-018]

SATISFACTION     [K-006]

SCEDOSPORIUM AURANTIACUM     [B-018]

SCFV     [C-023], [C-003]

SCHISTOSOMA MANSONI     [SP-24 - 4], [H-006], [SP-18 - 3]

SCHISTOSOMIASIS     [J-003], [I-025]

SCHIZOPHRENIA     [D-006]

SCORING FUNCTIONS     [C-024]

SCORPAENA PLUMIERI     [J-029], [M-032]

SCORPION TOXINS     [R-003]

SCORPION VENOM     [R-033], [R-010]

SCORPIONS     [E-031]

SEASONAL     [O-031]

SEAWEED     [I-033], [J-060], [I-011], [J-064], [O-020], [I-022], [O-008]

SEAWEEDS     [I-035]

SEC14-LIKE PROTEIN     [F-013]

SECONDARY METABOLITES     [J-023], [F-040], [F-004]

SECRETOME     [S-015], [J-025]

SECUNDARY METABOLITES     [H-005]

SEED     [J-032]

SEED OSMOPRIMING     [F-008]

SEED PROTEINS     [J-036]

SEEDS     [R-012]

SEGMENTATION     [I-038]

SELENIUM     [T-022], [J-050]

SELF-ASSEMBLY     [J-027]

SEMIOCHEMICAL EFFECT     [F-043]

SEPSIS     [Q-011]

SEQUENCING     [N-004]

SERINE PROTEASES     [M-043]

SERINE PROTEINASE INHIBITOR     [SP-05 - 4]

SERINE/ARGININE-RICH PROTEIN KINASE     [P-026]

SET     [B-023], [B-037]

SH-SY5Y     [B-033]

SHOTGUN PROTEOMICS     [S-004], [S-014], [S-005], [S-013]

SIALYLTRANSFERASE     [O-010]

SICKNESS BEHAVIOR     [Q-006]

SIGNALING     [SP-15 - 1], [SP-11 - 2]

SIGNALING PATHWAYS     [SP-04 - 1]

SIGNALING PROTEINS     [I-036]

SIGNATURE     [SP-02 - 2]

SILVER     [O-019]

SILVER NANOPARTICLES     [J-009]

SILVER STAINING     [J-059]

SILYBUM MARIANUM     [P-016]

SIMULATION     [SP-03 - 2]

SINGLET OXYGEN     [T-019]

SITE-DIRECTED MUTAGENESIS     [M-026]

SKELETAL MUSCLE     [A-027], [SP-15 - 4]

SKIN GLANDS     [R-025]

SMALL GTPASES     [SP-09 - ]

SMALL-MOLECULE INHIBITORS     [B-010]

SMOOTH MUSCLE CELL     [BM-03]

SNAIL     [S-008]

SNAKE SERUM     [M-014]

SNAKE VENOM     [M-028], [M-027], [G-013], [I-031], [J-063], [P-018], [I-020], [I-010], [I-021], [B-004], [B-003]

SNAKE VENOM PHOSPHOLIPASE A2     [B-014]

SNP     [C-019]

SOD3     [C-008], [C-018]

SOIL ENZYME ACTIVITY     [L-019]

SOIL ENZYMES     [L-005]

SOLID LIPID NANOPARTICLES     [A-040]

SOLID-STATE FERMENTATION     [L-023], [L-001]

SONIC HEDGEHOG     [B-021]

SORGHUM BICOLOR     [F-032], [F-017], [F-021]

SOYBEAN     [F-029]

SOYBEN     [S-020]

SPARE RESPIRATORY CAPACITY     [A-042]

SPECTROMERY     [E-042]

SPECTROSCOPY     [M-034]

SPHINGOLIPIDS     [H-008]

SPIDER     [E-046], [S-010], [SP-22 - 2]

SPIDER-VENOM PEPTIDE     [SP-22 - 1]

SPIRULAN     [O-030]

SPIRULINA MAXIMA     [O-030]

SPODOPTERA FRUGIPERDA     [E-015], [E-033]

SRPK     [P-017]

STABILITY     [J-038], [SP-16 - 4], [M-010], [SP-03 - 3]

STANDARD CURVE SIMULATION     [K-004]

STAPHYLOCOCCUS     [G-002]

STAPHYLOCOCCUS AUREUS     [F-033]

STARVATION STRESS     [J-007]

STEM CELLS     [CF-3], [SP-20 - 5]

STONEBREAKER     [R-007], [F-022]

STRIATUM     [SP-24 - 4]

STRINGENT RESPONSE     [G-021]

STROMAL CELLS     [SP-20 - 4]

STRUCTURAL BIOLOGY     [M-025], [M-029]

STRUCTURAL PARAMETERS     [L-030]

STRUCTURAL STABILITY     [G-018], [C-013]

STRUCTURE     [SP-16 - 4], [M-031], [M-011], [M-017]

STRYPHNODENDRON ADSTRINGENS     [S-003]

STUDENTS     [D-021]

STYABILITY     [L-029]

STZ-INDUCED DIABETES     [V-001]

SUGAR     [SP-11 - 1]

SUGARCANE     [L-019], [F-042]

SULFATED FUCAN     [O-019]

SULFATED FUCANS     [O-037]

SULFATED GALACTAN     [O-032], [O-009]

SULFATED GALACTAN-RICH FRACTIONS     [O-023]

SULFATED GALACTOMANNAN     [F-010]

SULFATED POLYSACCHARIDE     [O-008]

SULFATED POLYSACCHARIDES     [J-064], [SP-13 - 3], [O-030], [O-035]

SULFENIC ACID     [SP-09 - 1]

SULFITE     [SP-24 - 4]

SUPEROXIDE DISMUTASES     [M-038]

SUPPLEMENTATION     [T-025]

SURFACTANT PROTEIN     [S-002]

SYD-1     [A-030]

SYNAPSES     [SP-09 - 5]

SYNERGISTIC EFFECT     [L-026]

SYNTHETIC ANTIOXIDANTS     [SP-12 - 2]

SYNTHETIC BIOLOGY     [SP-25 - 1], [J-033]

SYNTHETIC PEPTIDE     [J-010]

SYSTEMS BIOLOGY     [N-006], [N-015]


Ttop

T CD8     [SP-18 - 1]

T. EVANSI     [L-021]

T1DM-INDUCED BONE LOSS     [V-002]

TAMARIND     [R-018]

TAMBAQUI     [G-017]

TARGETING     [SP-21 - 2]

TCA CYCLE     [SP-11 - 3]

TCNTPDASE-1     [H-019]

TEACHING     [K-014], [K-010]

TEACHING AND LEARNING     [K-005]

TEACHING OF BIOCHEMISTRY     [K-007]

TEACHING STRATEGIES     [K-011]

TELOMERASE     [H-003]

TELOMERE SHORTENING     [I-012]

TELOMERES     [H-012]

TEMPERATURE-RESPONSIVE GENES     [F-044]

TERRA     [H-012]

TETRANYCHUS SPP     [E-016]

TEXT ANALYTICS     [SP-19 - 1]

TGF- β1     [A-019]

TGF-β     [I-036]

TGFA, MTHFR AND MTR GENES     [I-001]

THERAPEUTIC     [SP-14 - 3]

THERAPY     [R-035], [SP-08 - 3]

THERMOPHILIC     [L-028]

THERMOREGULATION     [SP-20 - 5]

THERMOSTABILITY     [M-024]

THERMOTOLERANCE     [M-030]

THIAZOLIDINE-DIKETOPIPERAZINE MOLECULES     [P-002]

THIOACETAMIDE     [T-018]

THIOSEMICARBAZONES     [P-009]

THROMBOSIS     [M-042], [J-063]

THYMINE NUCLEOTIDE RECOGNITION     [J-018]

THYROID CANCER     [N-016]

TICK     [E-009], [E-026], [E-038], [E-007], [SP-05 - 2], [A-022], [E-023], [E-025]

TICK EMBRYO     [E-036]

TICK SALIVA     [SP-05 - 3]

TIGHT JUNCTION     [J-020]

TIGHT JUNCTIONS     [O-012]

TIME OF DRYING     [I-033]

TITANIUM     [V-007], [BM-05]

TLR     [T-007]

TLR4     [C-026]

TNAP     [V-009]

TNF-ALFA     [B-019]

TOPOISOMERASE IV     [R-015]

TOPOISOMERASE 2     [E-039]

TOR SIGNALING PATHWAY     [E-036]

TORSIN A     [M-030]

TOXIC PLANT     [F-004]

TOXICITY     [F-009], [P-007]

TOXICOLOGY     [U-001]

TOXIN-ANTITOXIN     [M-016]

TOXINOLOGY     [E-003]

TOXOPLASMA GONDII.     [B-029]

TPS1     [C-027]

TRANCRIPTOMICS AND PROTEOMICS TOOLS     [S-021]

TRANSCRIPTION     [E-026]

TRANSCRIPTIONAL REGULATION     [I-038]

TRANSCRIPTOME     [S-010]

TRANSCRIPTOMIC     [N-005]

TRANSCRIPTOMICS     [SP-22 - 4]

TRANSCRIPTS     [E-033]

TRANSDIFFERENTIATION     [BM-03]

TRANSGENIC     [S-020]

TRASTUZUMAB     [P-010]

TREE OF GOLD     [F-005], [F-003]

TREHALOSE     [C-027]

TREM     [T-007]

TREML4     [D-007]

TRIATOMA INFESTANS     [R-024]

TRIATOMINES     [H-007]

TRIBOLIUM CASTANEUM     [E-002]

TRICHODERMA REESEI     [J-022]

TRIOSEPHOSPHATE ISOMERASE     [E-023]

TRIPLARIS GARDNERIANA     [P-012]

TRIPLE NEGATIVE MAMMARY CANCER     [SP-20 - 3]

TRNA     [E-013]

TROPONIN C     [M-037]

TRPA1 CHANNEL     [SP-09 - 4]

TRUE DIGESTIBILITY     [R-008]

TRYPANOCIDAL DRUGS     [P-015]

TRYPANOSOMA CRUZI     [H-014], [H-004], [B-040], [S-019], [H-013], [A-035], [H-001], [N-011], [H-019], [SP-23 - 1], [SP-14 - 2]

TRYPANOSOMA EVANSI     [R-029]

TRYPANOSOMATIDS     [P-013]

TRYPANOSOMES     [CF-1]

TRYPANOSSOMA BRUCEI     [C-002]

TRYPANOTHIONE SYNTHETASE     [P-013]

TRYPSIN     [L-007], [R-032]

TRYPSIN BIOREACTOR     [L-027]

TRYPSIN INHIBITOR     [M-033], [R-031]

TRYPSINE-LIKE     [L-014]

TUBERCULOSIS     [M-016]

TUMOR FLUID     [S-006]

TUMOR-ASSOCIATED MACROPHAGE     [P-006]

TYPE 1 DIABETES     [BM-04]

TYPE 1 DIABETES MELLITUS     [BM-04]

TYROSINEMIA TYPE II     [Q-013], [A-026], [Q-012], [A-008]


Utop

UBIQUITIN     [B-011]

UCIDES CORDATUS     [L-025]

UDOTEA FLABELLUM     [O-032]

ULTRASMALL GOLD NANOPARTICLES     [J-066]

ULVA LACTUCA     [O-016]

UNCOUPLING     [SP-01 - 1]

UNGAL CELLS     [SP-13 - 4]

UNIVERSAL     [G-009]

UNIVERSITY     [SP-19 - 4]

UROGUANYLIN     [SP-21 - 4]

UROLITHIASE     [O-021]

UROLITHIASIS     [O-009]

USTILAGO MAYDIS     [L-004]

UVAIA JUICE     [D-023]


Vtop

VACCINE     [SP-05 - 2], [G-009]

VACCINE PLATFORM     [G-018]

VACUOLAR     [SP-21 - 1]

VARIANTS     [I-026]

VCAM-1     [D-019]

VEGF     [I-016]

VENOM     [M-032], [R-006], [E-046]

VENOM ACTIVATION     [E-003]

VIGNA UNGUICULATA     [F-011]

VIRTUAL SCREENING     [C-005]

VIRULENCE FACTORS     [G-007]

VIRUS-CELL INTERACTIONS     [G-008]

VIRUS-LIKE PARTICLE     [G-018]

VISCERAL LEISHMANIASIS     [D-015], [J-062], [N-017]

VISIBLE LIGHT     [T-028]

VITAMIN E     [A-016]


Wtop

WARBURG EFFECT     [A-039]

WATER RESTRICTION     [F-024]

WHEAT     [S-014]

WHITE ADIPOSE TISSUE (WAT)     [BM-01]

WNT     [O-011]

WNT PATHWAYS     [J-055]

WNT SIGNALING     [O-027]

WOLBACHIA     [E-034]


Xtop

XANTHOMONAS     [J-009]

XYLAN     [O-005]

XYLANASE     [L-013]

XYLELLA FASTIDIOSA     [G-004]

XYLOGLUCAN     [A-017]


Ytop

YEAST     [J-035], [T-020]

YELLOW FEVER     [G-010]

YOLK ORGANELLES     [E-043]


Ztop

ZEBRA FISH     [A-007]

ZEBRA-FISH     [A-037]

ZIKV STRAINS     [CF-6]

ZINC     [SP-12 - 3]

ZINC SUPPLEMENTATION     [BM-04]

ZINC SUPPLEMENTATION AND INSULIN THERAPY     [V-002]

ZN(II) COMPLEXES     [J-018]

 




2016 © All rights reserved to SBBq.
Adaltech